QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 nasdaq-jumps-150-points-us-pending-home-sales-rise

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 150 points on Monday. Following the market ...

Core News & Articles

Gainers PepGen (NASDAQ: PEPG) stock rose 114.3% to $5.7 during Thursday's regular session. The market value of their outst...

Core News & Articles

Gainers PepGen (NASDAQ: PEPG) shares rose 141.0% to $6.41 during Thursday's pre-market session. The market value of their ...

 predictive-oncology-announces-1-for-15-reverse-stock-effective-september-30-2025

Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug development and discovery, today announced that it will eff...

 predictive-oncology-announces-a-strategic-collaboration-with-every-cure-to-identify-and-prioritize-drugs-for-repurposing-to-improve-patient-outcomes-and-save-lives

Predictive Oncology Inc. (NASDAQ:POAI), a leader in AI-driven drug development and discovery, and Every Cure, a leading nonprof...

 predictive-oncology-q2-eps-022-misses-009-estimate-sales-2682k-down-from-67255k-yoy

Predictive Oncology (NASDAQ:POAI) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of...

 predictive-oncology-secures-10m-funding-to-drive-us-and-european-expansion-of-chemofx-and-fuel-ai-driven-drug-discovery

$10 million securities purchase agreement provides efficient and flexible funding in support of strategic multi-million dollar ...

 on-july-1-predictive-oncology-entered-equity-purchase-agreement-with-ya-ii-pn-ltd

-SEC Filing

Core News & Articles

Predictive Oncology Inc. (NASDAQ:POAI), a leader in AI-driven drug discovery, announced today the company has successfully deve...

Core News & Articles

Renovaro Inc. (NASDAQ:RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION